Beaumont Financial Partners LLC Boosts Stock Position in Danaher Co. (NYSE:DHR)

Beaumont Financial Partners LLC lifted its stake in Danaher Co. (NYSE:DHRGet Rating) by 2.6% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 50,032 shares of the conglomerate’s stock after buying an additional 1,265 shares during the quarter. Danaher makes up 1.1% of Beaumont Financial Partners LLC’s holdings, making the stock its 24th largest position. Beaumont Financial Partners LLC’s holdings in Danaher were worth $14,682,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the stock. City Holding Co. boosted its position in Danaher by 13.0% during the first quarter. City Holding Co. now owns 4,133 shares of the conglomerate’s stock worth $1,212,000 after purchasing an additional 475 shares in the last quarter. RDA Financial Network raised its holdings in shares of Danaher by 73.4% during the first quarter. RDA Financial Network now owns 2,763 shares of the conglomerate’s stock valued at $810,000 after acquiring an additional 1,170 shares during the last quarter. Wambolt & Associates LLC raised its holdings in shares of Danaher by 5.1% during the fourth quarter. Wambolt & Associates LLC now owns 1,035 shares of the conglomerate’s stock valued at $341,000 after acquiring an additional 50 shares during the last quarter. Selective Wealth Management Inc. raised its holdings in shares of Danaher by 500.0% during the first quarter. Selective Wealth Management Inc. now owns 348 shares of the conglomerate’s stock valued at $102,000 after acquiring an additional 290 shares during the last quarter. Finally, 1900 Wealth Management LLC raised its holdings in shares of Danaher by 2.6% during the first quarter. 1900 Wealth Management LLC now owns 1,969 shares of the conglomerate’s stock valued at $578,000 after acquiring an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 78.42% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research analyst reports. William Blair reissued an “outperform” rating on shares of Danaher in a report on Friday, April 22nd. StockNews.com raised Danaher from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 30th. Cowen cut their price target on Danaher to $340.00 in a report on Friday, July 22nd. Wells Fargo & Company cut Danaher from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $330.00 to $265.00 in a report on Monday, April 25th. Finally, Evercore ISI cut their price target on Danaher from $320.00 to $280.00 and set an “outperform” rating for the company in a report on Tuesday, July 5th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Danaher presently has an average rating of “Buy” and a consensus target price of $328.58.

Insider Buying and Selling at Danaher

In other Danaher news, Director Walter G. Lohr sold 3,906 shares of the firm’s stock in a transaction on Friday, July 22nd. The stock was sold at an average price of $273.84, for a total value of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares in the company, valued at $3,317,571.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Danaher news, Director Walter G. Lohr sold 3,906 shares of the firm’s stock in a transaction on Friday, July 22nd. The stock was sold at an average price of $273.84, for a total value of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares in the company, valued at $3,317,571.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Joakim Weidemanis sold 12,000 shares of Danaher stock in a transaction dated Monday, July 25th. The stock was sold at an average price of $271.13, for a total value of $3,253,560.00. Following the sale, the executive vice president now owns 74,398 shares in the company, valued at approximately $20,171,529.74. The disclosure for this sale can be found here. 11.20% of the stock is owned by insiders.

Danaher Stock Up 0.4 %

NYSE:DHR traded up $1.05 during midday trading on Friday, reaching $290.00. The company had a trading volume of 1,316,343 shares, compared to its average volume of 2,304,426. The firm has a market capitalization of $210.96 billion, a price-to-earnings ratio of 34.16, a PEG ratio of 2.32 and a beta of 0.86. The stock’s fifty day simple moving average is $261.98 and its 200-day simple moving average is $268.32. Danaher Co. has a 12-month low of $233.71 and a 12-month high of $333.96. The company has a current ratio of 1.75, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45.

Danaher (NYSE:DHRGet Rating) last released its earnings results on Thursday, July 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. The firm had revenue of $7.75 billion during the quarter, compared to analyst estimates of $7.29 billion. Danaher had a return on equity of 18.57% and a net margin of 20.61%. Danaher’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business posted $2.46 earnings per share. On average, sell-side analysts anticipate that Danaher Co. will post 10.39 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 29th. Shareholders of record on Friday, June 24th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Thursday, June 23rd. Danaher’s dividend payout ratio is presently 11.78%.

Danaher Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.